Thank you so much for support and your investment in Ventoux Biosciences and our mission to transform treatment for Dupuytren's Disease (DD) . Your generosity is helping us take a crucial step forward in transforming treatment options for Dupuytren’s disease. Your investments are instrumental in advancing VEN-201 through "proof of concept" studies using human Dupuytren's tissue—a pivotal milestone in our research journey.

As investors, I wanted to share that we now have three options for people to get involved and support our mission. The options include equity investments, including this WeFunder (Reg CF) option that you are familiar with, a Reg D option, and a new donation option where participants can make donations starting at $5.00. As we work to raise funds for the ex vivo proof of concept study - we are working to provide a range of options for support. These options are now updated and featured on the company website here.

Thank you again for your incredible support. If you know anyone who might connect with our mission, please feel free to share this fundraiser or our investor page with them.

Have a wonderful day, thank you.